Related Experiment Video
Updated: May 10, 2026

11:54
Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles
Published on: March 13, 2017
9.7K
Pushbutton-activated microfluidic cell-free biosensor for multiplexed pathogen detection
Dong Hyun Han1, Yurim Kim1, Yu Jin Park2
1Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea. jekyun@kaist.ac.kr.
Lab on a Chip
|October 10, 2025
Summary
A novel cell-free biosensor uses a multiplexed pushbutton-activated microfluidic device (mPAMD) for simultaneous pathogen detection. This accessible diagnostic platform offers high sensitivity and specificity for 16S rRNAs.
Area of Science:
- Biotechnology
- Microfluidics
- Biosensors
Background:
- Pathogen detection is crucial for public health.
- Existing methods often lack multiplexing capabilities or require complex instrumentation.
- Cell-free systems offer rapid and adaptable diagnostic solutions.
Purpose of the Study:
- To develop a novel cell-free biosensor for simultaneous detection of multiple 16S rRNAs.
- To integrate multi-step cell-free protein synthesis into a single microfluidic device.
- To create an accessible and intuitive diagnostic platform.
Main Methods:
- Development of a multiplexed pushbutton-activated microfluidic device (mPAMD).
- Integration of target-responsive cell-free protein synthesis with finger-pumping mechanism.
- Design and optimization of microchannels for efficient mixing and reagent distribution.
- Incorporation of multiplexed detection zones with pathogen-specific probes.
Main Results:
- Simultaneous detection of multiple 16S rRNAs achieved in a single device.
- Achieved a detection limit for 16S rRNA ranging from 1.69 to 7.39 pM.
- Demonstrated high sensitivity and specificity for pathogen identification.
- System corresponds to approximately 10^4 to 10^5 CFU mL^-1 of pathogens.
Conclusions:
- The mPAMD provides a simple, intuitive, and accessible multiplexed diagnostic platform.
- The developed cell-free biosensor addresses the demand for sensitive and specific pathogen detection.
- This technology holds potential for rapid point-of-care diagnostics.

